HLB Genex, Inc. Logo

HLB Genex, Inc.

Develops and produces customized enzyme and microbiome-based solutions.

187420 | KO

Overview

Corporate Details

ISIN(s):
KR7187420005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노1로 65(관평동), 대전광역시

Description

HLB Genex, Inc. is a biotechnology company that develops and produces customized enzyme and microbiome-based solutions. The company's core activities involve the research, development, and manufacturing of industrial special enzymes and bio-healthcare ingredients. Its key products include enzymes like Lactase for food applications, Catalase for eco-friendly industrial processes, and Proteinase K for molecular diagnostics. In the bio-healthcare segment, it produces Vitamin K2 (Menaquinone 7) for bone and cardiovascular health and Phytosphingosine for cosmeceuticals. The company utilizes proprietary platform technologies, such as Microbial Surface Display and Spore Biologics, to develop its products and advance its pipeline of microbiome therapeutics by identifying effector molecules, also known as postbiotics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-08-20 00:00
주권관련사채권의취득결정
Korean 37.5 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-07 00:00
전환가액의조정
Korean 12.7 KB
2025-07-07 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 13.3 KB
2025-06-30 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 18.3 KB
2025-06-26 00:00
기업설명회(IR)개최
Korean 6.6 KB
2025-06-10 00:00
기업설명회(IR)개최
Korean 6.7 KB
2025-05-21 00:00
타법인주식및출자증권취득결정
Korean 25.4 KB
2025-05-13 00:00
분기보고서 (2025.03)
Korean 1.8 MB
2025-05-12 00:00
기업설명회(IR)개최
Korean 6.9 KB
2025-05-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-30 00:00
주식등의대량보유상황보고서(일반)
Korean 240.1 KB
2025-04-17 00:00
주식등의대량보유상황보고서(일반)
Korean 239.0 KB
2025-04-17 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all HLB Genex, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Genex, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Genex, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.